Cardiology Research, ISSN 1923-2829 print, 1923-2837 online, Open Access |
Article copyright, the authors; Journal compilation copyright, Cardiol Res and Elmer Press Inc |
Journal website https://www.cardiologyres.org |
Case Report
Volume 9, Number 1, February 2018, pages 46-49
Critical Management of Severe Hypotension Caused by Amlodipine Toxicity Managed With Hyperinsulinemia/Euglycemia Therapy Supplemented With Calcium Gluconate, Intravenous Glucagon and Other Vasopressor Support: Review of Literature
Table
1) Decontamination |
a) Activated charcoal: single dose of 50 g for adults |
b) Polyethylene glycol whole bowel irrigation: 2 L/h in adults until rectal effluent is clear |
2) Supportive therapy |
a) Intravenous fluids |
b) Atropine: 1 mg IV (can be repeated up to 3 mg total) |
3) Antidotes |
a) Calcium salts: i) calcium chloride: 10 - 20 mL of a 10% solution administered over 10 min (can repeat dose if no effect); ii) calcium gluconate: 30 - 60 mL of a 10% solution (dose can be repeated if no effect); iii) continuous infusion with either salt: 0.5 mEq of Ca/kg/h |
b) Glucagon: 5 mg IV bolus, can be repeated twice at 10 min intervals |
4) Phosphodiesterase inhibitor (e.g., amrinone and milrinone) |
5) Adrenergic agents (e.g., norepinephrine and dopamine, etc.) |
6) HIE |
a) Regular insulin bolus of 0.1 U/kg IV and then continuous infusion of 0.2 - 0.5 U/kg/h |
b) Dextrose 25 - 50 g bolus followed by a continuous infusion of 0.5 g glucose/kg/h that can be titrated to appropriate blood glucose. |
7) Invasive therapy |
a) Transvenous pacing |
b) Intraaortic balloon pump |
c) Cardiopulmonary bypass |
d) Extracorporeal membrane oxygenation |